3DEM History and Genealogy 1968-2011
Welcome to the Web Page on the History of 3-Dimensional Electron Microscopy in Biology
Since the inception of the field of 3-Dimensional Electron Microscopy in Biology in 1968 there has been remarkable growth in the number of labs and scientists active in the field of 3DEM.
The aim of this website is to provide links to some of the original papers which spawned the field and reviews which have chronicled the subsequent development of the field. Several of these resources are published personal accountings by colleagues who were central in the field, and also narratives written especially for this project.
An attempt has been made to present a genealogy reflecting the original groups in the field and to show how the field has propagated from the few pioneer laboratories in 3DEM, and the interrelationships between them.
The genealogy data in the map has purposely been cut off at the year 2011. This arose because of the almost exponential rise in 3DEM activity since this date. We felt that chronicling the early steps of the development of the field would provide a valuable resource in understanding how the field evolved.
Here is a link to the criteria used for inclusion in the genealogy.
We rely on you, our colleagues, to make further contributions to the website and to guide us in the accuracy of the facts we present. Please feel free to contact us (Alexis, Martin, Ardan)!
Network Visualization
This is an attempt at an academic genealogy of the field of 3D EM and is a work in progress.
Academic genealogy: Frequently Asked Questions
This genealogy aims to record the growth of the field of 3D EM from 1968 to 2011
Who is included?
Researchers who hold or have held permanent positions and who have made a significant contribution to the field of 3D EM. PhD students, postdocs and other non-permanent scientists are not included. Tenure-track faculty are included.
Technical Staff with more than 5 publications in the field of 3DEM are also included in the list.
What do arrows signify?
Links denote mentorship. Typically, PhD supervisor – student and PI – postdoc relationships are denoted by links. If a person trained or worked in more than one lab, these relationships may be indicated.
Why are some nodes larger, more visible than others?
The choice of which nodes to emphasize aims to reflect:
- Those scientists who initiated the field of 3D EM
- The number of their academic “descendants”
- The fact that some researchers entered the field independently of others, in a sense becoming “first-generation” contributors
Why is X not included? I can see errors, can they be corrected?
Since there is no authoritative source for information needed to compile this genealogy we rely on feedback to ensure there are no omissions or other mistakes.
Development of the field of 3DEM
Publications related to the history of 3D EM
| David DeRosier | 3D reconstruction from electron micrographs a personal account of its development | Methods Enzymol. 2010;481:1-24 |
| Bob Glaeser | Review: Electron Crystallography: Present Excitement, a Nod to the Past, Anticipating the Future | J Struct Biol. 1999 Dec 1;128(1):3-14 |
| Ken Taylor, Bob Glaeser | Retrospective on the early development of cryoelectron microscopy of macromolecules and a prospective on opportunities for the future | J Struct Biol. 2008 Sep;163(3):214-23 |
| Obituary: Walter Hoppe | J. Appl. Cryst. (1987) 20, 324-325 | |
| Bruno Strasser, Jacques Dubochet | Obituary: Eduard Kellenberger (1920-2004) | Nature. 2005 Feb 24;433(7028):817 |
| Marin van Heel | Jean-Pierre Bretaudière (1946-2008) and the early days of multivariate statistics in electron microscopy | In: "An electronic text book: Electron microscopy in Life Science", 3D-EM Network of Excellence, Editors: A. Verkley and E. Orlova (2009) |
| R. Nuzzo | Profile of Chikashi Toyoshima | Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1165-7 |
| Aaron Klug | Aaron Klug - Autobiography | Nobelprize.org. 17 Jul 2011 |
| Don Caspar, David DeRosier | The 1982 Nobel Prize in chemistry | Science. 1982 Nov 12;218(4573):653-5 |
| John Finch | A Nobel Fellow on Every Floor | Book published by MRC/LMB |
| Anthony Crowther | From Envelopes to Atoms: The Remarkable Progress of Biological Electron Microscopy | Adv Protein Chem Struct Biol. 2010;81:1-32. |
| Viruses and the development of quantitative biological electron microscopy | Notes Rec R Soc Lond. 2004 Jan;58(1):65-81. | |
| Nikolai Andreevich Kiselev | Nikolai Andreevich Kiselev (On the Occasion of His 80th Birthday) | Kristallografiya, 2008, Vol. 53, No. 6, pp. 1149–1150. translated in Crystallography Reports, 2008, Vol. 53, No. 6, pp. 1091–1092 |
| Wolfgang Baumeister | A voyage to the inner space of cells | Protein Sci. 2005 January; 14(1): 257–269. |
| Arthur L Robinson | Electron Microscopy: Imaging Molecules in Three Dimensions | Science 1976 April; Vol. 192 no. 4237 pp. 360-400 |
| Jacques Dubochet | Cryo-EM—the first thirty years | Journal of Microscopy 2011; Vol. 245 no. 3 pp. 1-4 |
| Aaron Klug | A Long Way from DurbanA Biography | Cambridge University Press, 2017 |
| Joachim Frank | Single-particle Cryo-electron Microscopy: The Path Toward Atomic Resolution/Selected Papers Of Joachim Frank With Commentaries (Series in Structural Biology) | April 6, 2018 |
Original personal narratives
These narratives were specially provided to this 3DEM history website by the authors below. We welcome further contributions.
| Robert Josephs | A profile of a researcher in the field of electron crystallography | October 2015 |
| Michael Rossmann | A short scientific autobiography of Michael G. Rossmann | September 2011 |
| Ondreij Krivanek | Ondrej Krivanek’s contribution to microscopy: Memories of an adventure! | August 2018 |
Other Links
Web of stories: video interview of Aaron Klug & Nobel interview with Aaron KlugContributors
Hebrew University of Jerusalem and the National Cancer Institute, NIH
Quick links
Recent Entries
(Show all)Consensus map of M. pneumoniae 30S small ribosomal subunit in native cells
Map of M. pneumoniae 70S transertion-like (flexible RNAP) in native cells
Map of M. pneumoniae 30S iT-TC (flexible) in pseudouridimycin-treated cells
Map of M. pneumoniae 50S membrane complex in pseudouridimycin-treated cells
Map of M. pneumoniae 70S A/P,P/E, EF-G in pseudouridimycin-treated cells
Map of M. pneumoniae 50S membrane complex in fidaxomicin-treated cells
Map of M. pneumoniae 30S empty/factorless in fidaxomicin-treated cells
Map of M. pneumoniae 50S empty/factorless in fidaxomicin-treated cells
Map of M. pneumoniae 70S membrane complex in chloramphenicol-treated cells
Map of M. pneumoniae 30S iT-TC (flexible RNAP recentered subset) in pseudouridimycin-treated cells
Map of M. pneumoniae 70S transertion-like (collided RNAP) in pseudouridimycin-treated cells
Map of M. pneumoniae 30S iT-TC (flexible) in fidaxomicin-treated cells
Map of M. pneumoniae 50S membrane complex in chloramphenicol-treated cells
Map of M. pneumoniae 30S iT-TC (flexible RNAP recentered subset) in native cells
Map of M. pneumoniae 70S transertion-like (stable RNAP) in native cells
Map of M. pneumoniae 70S transertion-like (collided RNAP) in native cells
Consensus map of M. pneumoniae 30S small ribosomal subunit in pseudouridimycin-treated cells
Map of M. pneumoniae 70S eT-TC (flexible RNAP recentered subset) in native cells
Consensus map of M. pneumoniae 70S ribosome in pseudouridimycin-treated cells
Map of M. pneumoniae 50S RRF, EF-G in pseudouridimycin-treated cells
Map of M. pneumoniae 30S IF1/3 tRNA in pseudouridimycin-treated cells
Map of M. pneumoniae 50S empty/factorless in pseudouridimycin-treated cells
Consensus map of M. pneumoniae 50S large ribosomal subunit in pseudouridimycin-treated cells
Map of M. pneumoniae 30S empty/factorless in pseudouridimycin-treated cells
Map of M. pneumoniae 30S IF1/2/3 tRNA in pseudouridimycin-treated cells
Map of M. pneumoniae 50S trigger factor in pseudouridimycin-treated cells
Map of M. pneumoniae 70S A/P,P/E in pseudouridimycin-treated cells
Map of M. pneumoniae 50S late/inactive in pseudouridimycin-treated cells
Map of M. pneumoniae 30S IF1/2/3 in pseudouridimycin-treated cells
Map of M. pneumoniae 70S dome complex in pseudouridimycin-treated cells
Map of M. pneumoniae 70S A*,P/E, EF-G in pseudouridimycin-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P in pseudouridimycin-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P,E in pseudouridimycin-treated cells
Consensus map of M. pneumoniae 30S small ribosomal subunit in fidaxomicin-treated cells
Map of M. pneumoniae 70S trigger factor in pseudouridimycin-treated cells
Consensus map of M. pneumoniae 50S large ribosomal subunit in fidaxomicin-treated cells
Consensus map of M. pneumoniae 70S ribosome in fidaxomicin-treated cells
Map of M. pneumoniae 70S eT-TC (collided) in pseudouridimycin-treated cells
Map of M. pneumoniae 70S membrane complex (no RNAP) in pseudouridimycin-treated cells
Map of M. pneumoniae 30S late biogenesis in fidaxomicin-treated cells
Map of M. pneumoniae 30S iT-TC (stable) in fidaxomicin-treated cells
Map of M. pneumoniae 50S PTC flipped out in fidaxomicin-treated cells
Map of M. pneumoniae 50S trigger factor in fidaxomicin-treated cells
Map of M. pneumoniae 70S tmRNA-SmpB,P,E in fidaxomicin-treated cells
Map of M. pneumoniae 30S IF1/3 tRNA in chloramphenicol-treated cells
Map of M. pneumoniae 50S late/inactive in chloramphenicol-treated cells
Map of M. pneumoniae 30S IF2 (all, shifted) in chloramphenicol-treated cells
Map of M. pneumoniae 50S trigger factor in chloramphenicol-treated cells
Map of M. pneumoniae 30S IF2 tRNA in chloramphenicol-treated cells
Map of M. pneumoniae 30S IF1/2/3 tRNA in chloramphenicol-treated cells
Map of M. pneumoniae 70S dome complex in chloramphenicol-treated cells
Map of M. pneumoniae 70S A,P,EOUT in chloramphenicol-treated cells
Map of M. pneumoniae 50S EF-Tu A/T, tmRNA-SmpB, E in chloramphenicol-treated cells
Map of M. pneumoniae 50S PTC flipped out, P in chloramphenicol-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P,E in chloramphenicol-treated cells
Map of M. pneumoniae 70S trigger factor in chloramphenicol-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P in chloramphenicol-treated cells
Map of H. sapiens 60S large ribosomal subunit with Sec61-TRAP-OSTA translocon
Map of M. pneumoniae 30S iT-TC (stable) in pseudouridimycin-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P in fidaxomicin-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,P,E in fidaxomicin-treated cells
Map of M. pneumoniae 70S trigger factor in fidaxomicin-treated cells
Consensus map of M. pneumoniae 30S small ribosomal subunit in chloramphenicol-treated cells
Map of M. pneumoniae 70S EF-Tu A/T,E in fidaxomicin-treated cells
Consensus map of M. pneumoniae 70S ribosome in chloramphenicol-treated cells
Consensus map of M. pneumoniae 50S large ribosomal subunit in chloramphenicol-treated cells
Map of M. pneumoniae 30S iT-TC (flexible) in chloramphenicol-treated cells
Map of M. pneumoniae 50S empty/factorless in chloramphenicol-treated cells
Map of M. pneumoniae 70S membrane complex in fidaxomicin-treated cells
Structure of histone H1 in an import-chaperone complex with importin beta and importin 7
Cryo-EM structure of Clostridium perfringens pili CppA in complex with CppB
Flagellar motor structure from Borrelia burgdorferi DflhG mutant by subvolume averaging
Focused map of the external DII domain of RUVBL2 in complex with DPCD
Focused map of the external DII domain of RUVBL2 in complex with DPCD
Cryo-EM structure of human CCDC103/DNAAF19 in complex with RUVBL1/2
Focused map of the external DII domain of RUVBL2 in complex with DPCD
Focused map of human DNAAF19-RUVBL1/2 without the external DII domains.
Focused map of the external DII domain of RUVBL2 in complex with DPCD
Ribosome-dome complex including the Sec-translocon (SecYEG-SecA-SecDF) from antibiotics treated Mycoplasma pneumoniae cells (Combined)
Closed conformation dome complex including the Sec-translocon (SecYEG-SecA-SecDF) in untreated Mycoplasma pneumoniae cells
Focused map of the external DII domain of RUVBL2 in complex with DPCD
Open conformation dome complex including the Sec-translocon (SecYEG-SecA-SecDF) in untreated Mycoplasma pneumoniae cells
Cryo-EM structure of UBA6 in complex with FAT10 in the pre-adenylation state.
Cryo-EM structure of UBA6-UbDha-UBE2Z trapped ternary complex (singly loaded)
Cryo-EM structure of UBA6-UbDha-UBE2Z trapped ternary complex (doubly loaded)
Cryo-EM structure of UBA6 in complex with FAT10 in the post-thiolation state.
CryoEM structure of monoclonal Fab 047-09 1A02 binding the lateral patch of influenza virus H1 HA (A/California/04/2009 H1N1)
Murine RNF213 bound to maltoheptaose (Focused refinement of ATPase domain)
Murine RNF213 bound to maltoheptaose (Focused refinement of E3 module)
Murine RNF213 bound to maltoheptaose (Focused refinement of CBM20 domain)
Murine RNF213 bound to maltoheptaose (Focused refinement of top of stalk)
Murine RNF213 bound to maltoheptaose (Focused refinement of stalk)
Murine RNF213 bound to maltoheptaose (Focused refinement of E3 shell)
Cryo-EM structure of 3-methylcrotonyl-CoA carboxylase (MCC) complex (CT-engaged BCCP state) from Mycobacterium smegmatis
Cryo-EM structure of 3-methylcrotonyl- CoA carboxylase (MCC) complex (BC-engage BCCP state) from Mycobacterium smegmatis
Mouse 80S ribosome, eL41 KO (sg2 C11), weak P/E-site tRNA, weak P/E-site tRNA
Cryo-EM structure of 3-methylcrotonyl-CoA carboxylase (MCC) complex (BC-engaged BCCP state)from Mycobacterium smegmatis
Structure of alpha subunit of class Ib Ribonucleotide reductase in Mycobacteria (apo form)
cryo-EM structure of PSII D1-S264V from Thermosynechococcus vestitus BP-1
cryo-EM structure of PSII PsbA3-S264V in complex with DCMU from Thermosynechococcus vestitus BP-1
Cryo-EM Structure of the 12-Mer ATPase Complex YsaN from the Type III Secretion System of Yersinia enterocolitica
Cryo-EM structure of PSII PsbA3-S264V from Thermosynechococcus vestitus BP-1 (local refinement)
Cryo-EM structure of PI3Kalpha E542K mutation in complex with STX-478
Cryo-EM structure of PI3Kalpha H1047R mutation in complex with STX-478
Cryo-EM structure of PI3Kalpha E545K mutation in complex with STX-478
Cryo-EM structure of the Arabidopsis thaliana C4S4M4-type PSII supercomplex
Cryo-EM structure of the Arabidopsis thaliana C2S2M2-type PSII supercomplex
Fusion protein of Helicoverpa armigera nucleopolyhedrovirus in the uncleaved prefusion state
Structure of the intial complex in filament assembly at 3.31 angstroms resolution, conformation 1.
Structure of dimeric Tribolium castaneum (Tc) PINK1 L552R mutant in prime-activation conformation
Structure of dimeric phosphomimetic mutant of Tribolium castaneum (Tc) PINK1
Structure of dimeric autoinhibited Tribolium castaneum (Tc) PINK1 L552R mutant in complex with Ca2+
Structure of dimeric Tribolium castaneum (Tc) PINK1 L552R mutant in complex with Ca2+
Structure of dimeric autoinhibited Tribolium castaneum (Tc) PINK1 L552R mutant
LPT translocon complex from Flavobacter johnsoniae - focus volume, membrane and extracellular regions
LPT translocon complex from Flavobacter johnsoniae - consensus volume
LPT translocon complex from Flavobacter johnsoniae - focus volume, periplasmic regions
CD4 binding site and gp41-base mouse polyclonal antibodies in complex with BG505 GT1.1 SOSIP following saRNA construct GR2 immunization
CD4 binding site mouse polyclonal antibodies in complex with BG505 GT1.1 SOSIP following saRNA construct GR14 immunization
Structure of Human Argonaute2-miR200b RISC bound to 13nt long target in closed conformation
Structure of Human Argonaute2-miR200b RISC bound to 30nt long target RNA
Structure of Human Argonaute2-miR200b RISC bound to 13nt long target in open conformation
CD4 binding site mouse polyclonal antibodies in complex with BG505 GT1.1 SOSIP following saRNA construct GR6 immunization
CD4 binding site mouse polyclonal antibodies in complex with BG505 GT1.1 SOSIP following saRNA construct GR16 immunization
Structure of Human Argonaute2-miR200b RISC bound to 14nt long target in complex with kinase CK1alpha
Structure of Human Argonaute2-miR200b RISC bound to 14nt long target RNA
Structure of Human Argonaute2-miR200b RISC bound to 30nt long target in complex with kinase CK1alpha
Cryo-EM structure of Nitrogenase MoFe protein from Methanosarcina acetivorans bound to the NifI inhibitor complex in strictly anaerobic condition
Local Refinement of agonist/PAM bound mGluR8 chain B CRD and TMD when in complex with beta-arrestin-1
Local refinement of agonist-bound mGluR8 CRD and TMD in complex to G protein heterotrimer
Local Refinement of mGluR8 LBD when in complex with beta-arrestin-1
Local refinement of LBD of mGluR8 bound to agonist, PAM, and G proteins
Local refinement of agonist/PAM bound mGluR8 chain A LBD and CRD when in complex with beta-arrestin-1
Consensus non-uniform refinement map of agonist/PAM bound mGluR8 in complex with beta-arrestin-1
Local Refinement of mGluR8 TMD and G protein heterotrimer in complex
Local Refinement of G protein heterotrimer bound to scFv14 when in complex with active mGluR8
Cryo-EM structure of NifI free Nitrogenase MoFe protein from Methanosarcina acetivorans
Non-uniform refinement consensus map of mGluR8 bound to agonist, PAM, and G protein heterotrimer
Cryo EM structure of a formate acetyltransferase (PFL) from Amygdalobacter nucleatus in complex with CoA
GluA2-STZ desensitized state with partial agonist FW at 25 degrees C (full-length composite)
GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (full-length composite)
GluA2-STZ desensitized state with partial agonist NOW at 25 degrees C (full-length composite)
GluA2-STZ pre-active state with partial agonist NOW at 25 degrees C (full-length composite)
GluA2-STZ open state with partial agonist NOW at 25 degrees C (full-length composite)
GluA2-STZ desensitized state with partial agonist FW at 25 degrees C (ATD only)
GluA2-STZ open state with partial agonist IW at 25 degrees C (full-length composite)
GluA2-STZ open state with full agonist glutamate (Glu) at 25 degrees C (full-length composite)
GluA2-STZ open state with partial agonist FW at 25 degrees C (full-length composite)
GluA2-STZ desensitized state with full agonist glutamate (Glu) at 25 degrees C (full-length composite)
GluA2-STZ desensitized state with partial agonist FW at 25 degrees C (LBD-TMD only)
GluA2-STZ desensitized state with partial agonist FW at 25 degrees C (consensus)
GluA2-STZ open state with partial agonist FW at 25 degrees C (ATD only)
GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (consensus)
GluA2-STZ open state with partial agonist FW at 25 degrees C (consensus)
GluA2-STZ open state with partial agonist IW at 25 degrees C (LBD-TMD only)
GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (LBD-TMD only)
GluA2-STZ desensitized state with partial agonist NOW at 25 degrees C (TMD only)
GluA2-STZ desensitized state with partial agonist NOW at 25 degrees C (ATD only)
GluA2-STZ open state with partial agonist FW at 25 degrees C (LBD-TMD only)
GluA2-STZ open state with partial agonist NOW at 25 degrees C (consensus)
GluA2-STZ open state with partial agonist IW at 25 degrees C (consensus)
GluA2-STZ pre-active state with partial agonist kainic acid (KA) at 25 degrees C (ATD only)
GluA2-STZ open state with partial agonist IW at 25 degrees C (ATD only)
GluA2-STZ pre-active state with partial agonist NOW at 25 degrees C (LBD-TMD only)
GluA2-STZ open state with partial agonist NOW at 25 degrees C (LBD-TMD only)
GluA2-STZ pre-active state with partial agonist NOW at 25 degrees C (ATD only)
GluA2-STZ desensitized state with partial agonist NOW at 25 degrees C (consensus)
GluA2-STZ open state with partial agonist NOW at 25 degrees C (ATD only)
GluA2-STZ pre-active state with partial agonist NOW at 25 degrees C (consensus)
GluA2-STZ desensitized state with full agonist glutamate (Glu) at 25 degrees C (ATD only)
GluA2-STZ desensitized state with full agonist glutamate (Glu) at 25 degrees C (consensus)
GluA2-STZ desensitized state with full agonist glutamate (Glu) at 25 degrees C (LBD-TMD only)
GluA2-STZ open state with full agonist glutamate (Glu) at 25 degrees C (consensus)
GluA2-STZ open state with full agonist glutamate (Glu) at 25 degrees C (TMD only)
GluA2-STZ open state with full agonist glutamate (Glu) at 25 degrees C (LBD-TMD only)
Cryo-EM structure of Nitrogenase MoFe protein from Methanosarcina acetivorans bound to the NifI inhibitor complex in C3 symmetry
GluA2-STZ open state with full agonist glutamate (Glu) at 25 degrees C (ATD only)
GluA2-STZ desensitized state with full agonist glutamate (Glu) at 25 degrees C (TMD only)
The spike protein of HCoV-OC43 obtained from data collected on 100 kV Tundra at 180kX magnification with Falcon C detector
RNA polymerase II on Super pause sequence in the pre-translocated state
The spike protein of HCoV-OC43 obtained from data collected on 100 kV Tundra at 230 kX magnification with Falcon C detector
RNA polymerase II on Super pause sequence in the sidetracked state
Cryo-EM structure of trimeric Nitrogenase MoFe protein from Methanosarcina acetivorans
Structure of the CX3CL1.44-US28-GqiN18-scFv16 in the E-state, chemokine domain fully modeled
Structure of the CX3CL1.44-US28-GqiN18-scFv16 in the C'-state with AHD visible
Structure of the CX3CL1.44-US28-GqiN18-scFv16 in the C-state, full chemokine domain modeled
E.coli ribosome reconstruction from frames 1-40, not dose weighted
human type ribosome reconstruction from frames 1-20, not dose weighted
E.coli ribosome reconstruction from frames 1-20, not dose weighted
human type ribosome reconstruction from frames 1-40, not dose weighted
E.coli ribosome reconstruction from frames 1-80, not dose weighted
gp39 protein from Escherichia phage vB_EcoS_NBD2, unbent tubule, helix refine consensus map
gp39 protein from Escherichia phage vB_EcoS_NBD2, unbent tubule, focused map 2
gp39 protein from Escherichia phage vB_EcoS_NBD2, unbent tubule, focused map 1
sx20S complex (NSF-alphaSNAP-syntaxin-1a), non-hydrolyzing, class 1
sx20S complex (NSF-alphaSNAP-syntaxin-1a), 4:4 alphaSNAP-syntaxin-1a subcomplex local refinement, non-hydrolyzing, class 1
Cryo-EM structure of trimeric Nitrogenase MoFe protein from Methanosarcina acetivorans bound to the NifI inhibitor complex
Neurotensin Receptor 1 (NTSR1) bound to Octotensin in complex with Gi3 in the Canonical Orientation
Neurotensin Receptor 1 (NTSR1) bound to Octotensin in complex with Gi3 in the Non-Canonical Orientation
Structure of HCoV-229E spike proteins on virions by subtomogram averaging: RBD-closed and S2-compact
CryoEM structure of carbon monoxide dehydrogenase from Ruminococcus flavefaciens
Structure of HCoV-229E spike proteins on virions by subtomogram averaging: RBD-closed and S2-loose
Human Slo1-Charybdotoxin complex under divalent chelated condition - gating ring masked map
Human Slo1-PenitremA complex under divalent chelated condition - gating-ring masked out
Human Slo1-PenitremA complex under divalent chelated condition - full model
Human Slo1-Charybdotoxin complex under divalent chelated condition
Human Slo1-Iberiotoxin complex under divalent chelated condition - gating ring masked map
Human Slo1-Paxilline complex under divalent chelated condition - gating-ring masked
Human Slo1-paxilline complex under divalent chelated condition - full model
Consensus map of M. pneumoniae 50S large ribosomal subunit in native cells
